Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02775461 · ClinicalTrials.gov registry record
Pancreas Registry and High Risk Registry
A clinical trial of Pancreas Cancer and Chronic Pancreatitis, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 1,368
- Enrollment target
- 2
- Study locations
NCT02775461 is a study of Pancreas Cancer and Chronic Pancreatitis that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,368 participants, above the 882-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (55% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT02775461, a study of Pancreas Cancer and Chronic Pancreatitis, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 1,368 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to establish a registry of patients with pancreatic diseases. Patients included in the registry may include those with: pancreatic cancer, precancerous lesions of the pancreas, inflammatory lesions of the pancreas, cystic lesions of the pancreas, and patients at high-risk of pancreatic cancer such as those with a family history of pancreatic cancer or with a family history of a syndrome known to be associated with pancreatic cancer. Pancreatic cancer is the fourth leading cause of death from cancer in the United States. However, little is known about the development of pancreatic cancer and pancreatic diseases in individuals with the above conditions. Knowledge of how family history, environmental exposures, and inflammatory lesion of the pancreas contribute to the development of pancreatic cancer and pancreatic diseases is essential. You may qualify to take part in this research study because you have inflammation in the pancreas, a pancreatic cyst, pre-cancerous lesions of the pancreas, pancreatic cancer, a family history of pancreatic cancer, or a family history of a syndrome known to be associated with pancreatic cancer. We will also be collecting a blood sample from all participants for DNA isolation. Sometimes we are born with genes or DNA that give us an increased or decreased chance of developing an illness later in life. Genetic material will be isolated from your blood for further study. You may also choose to provide additional blood samples for serum and plasma extraction. Serum and plasma are components of the blood which can be used to measure indicators of disease in the blood, called biomarkers,for pancreatic diseases. Clinical data and biological specimens contained in this study may be used for a wide variety of future related studies to the cause, diagnosis, outcome and treatment of pancreatic cancer. Funds for conducting this research are provided by Mount Sinai.
Conditions Studied
Study Locations (2)
New York
- Mount Sinai West - New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,368 participants |
| Start Date | 2013-03-01 |
| Est. Completion | 2033-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02775461
The ClinicalTrials.gov registry entry for NCT02775461 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,368 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 882-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (55% higher). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Pancreas Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT02775461 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02775461 about?
NCT02775461 is a clinical study titled "Pancreas Registry and High Risk Registry". The purpose of this study is to establish a registry of patients with pancreatic diseases. Patients included in the registry may include those with: pancreatic cancer, precancerous lesions of the pancreas, inflammatory lesions of the pancreas, cystic lesions of the pancreas, and patients at high-ris...
What is the current status of trial NCT02775461?
This trial is currently recruiting. The enrollment target is 1,368 participants. The study started on 2013-03-01. Estimated completion is 2033-01.
What conditions does trial NCT02775461 study?
This clinical trial studies the following conditions: Pancreas Cancer, Chronic Pancreatitis, Pancreatic Cyst, Pancreatitis, Genetic Mutations.
Who is sponsoring clinical trial NCT02775461?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02775461 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreas Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
RECRUITING · Phase 2
-
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
RECRUITING
-
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
-
The Cancer of the Pancreas Screening-5 CAPS5)Study
RECRUITING · Phase 3
-
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.